Related references
Note: Only part of the references are listed.Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glueck et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Jeanne M. V. Louderbough et al.
MOLECULAR CANCER RESEARCH (2011)
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Markus Ringner et al.
PLOS ONE (2011)
Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways
Aaron E. Hoffman et al.
BMC CANCER (2010)
The Core Circadian Gene Cryptochrome 2 Influences Breast Cancer Risk, Possibly by Mediating Hormone Signaling
Aaron E. Hoffman et al.
CANCER PREVENTION RESEARCH (2010)
Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Clock-Cancer Connection in Non-Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2
Aaron E. Hoffman et al.
CANCER RESEARCH (2009)
Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study
Yong Zhu et al.
CANCER RESEARCH (2009)
Gene expression profiling of the tumor microenvironment during breast cancer progression
Xiao-Jun Ma et al.
BREAST CANCER RESEARCH (2009)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
Gulisa Turashvili et al.
BMC CANCER (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-Actin
Veronique Orian-Rousseau et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson et al.
CANCER CELL (2006)
A network-based analysis of systemic inflammation in humans
SE Calvano et al.
NATURE (2005)
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
L Radvanyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer
MA Gauger et al.
CANCER RESEARCH (2005)
Coupling of human circadian and cell cycles by the timeless protein
K Ünsal-Kaçmaz et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
HJ Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (Macrophage-Colony stimulating factor) production and breast tumor progression
LYW Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The circadian clock: Pacemaker and tumour suppressor
LN Fu et al.
NATURE REVIEWS CANCER (2003)
Coordination of circadian timing in mammals
SM Reppert et al.
NATURE (2002)
Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells
GE Duffield et al.
CURRENT BIOLOGY (2002)
Share Paper
